Literature DB >> 11999354

The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.

Masahiro Masuya1, Naoyuki Katayama, Natsuki Hoshino, Hiroyoshi Nishikawa, Seiji Sakano, Hiroto Araki, Hidetsugu Mitani, Hirohito Suzuki, Hiroyuki Miyashita, Kyoko Kobayashi, Kazuhiro Nishii, Nobuyuki Minami, Hiroshi Shiku.   

Abstract

The Notch/Notch ligand system controls diverse cellular processes. The proteolytic cleavage generates transmembrane and soluble forms of Notch ligands. We examined the effect of a soluble Notch ligand, human Jagged-1, on human cord blood (CB) CD34+ cells, under serum-deprived conditions, using soluble human Jagged-1-immunoglobulin G1 chimera protein (hJagged-1). Soluble hJagged-1 inhibited myeloid colony formation but not erythroid-mix or erythroid colony formation, in the presence of stem cell factor (SCF), interleukin-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF, thrombopoietin, and erythropoietin. Cytological analysis revealed that the decrease in myeloid colonies resulted mainly from the inhibition of macrophage colony formation. Furthermore, soluble hJagged-1 led to the inhibition of macrophage colony formation supported by M-CSF plus SCF and GM-CSF plus SCF. Delayed-addition experiments and the analysis of colony sizes demonstrated that soluble hJagged-l inhibited the growth of macrophage progenitors by acting in the early stage of macrophage development. The direct action of hJagged-1 was confirmed by the enhanced expression of the HES-1 (hairy enhancer of the split-1) gene. These results suggest that soluble hJagged-1 may regulate human hematopoiesis in the monocyte/macrophage lineage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999354     DOI: 10.1007/bf02982040

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  51 in total

1.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.

Authors:  K Nishii; K Kita; H Miwa; M Shikami; M Taniguchi; E Usui; N Katayama; H Shiku
Journal:  Int J Hematol       Date:  2000-06       Impact factor: 2.490

3.  Murine Delta homologue, mDelta1, expressed on feeder cells controls cellular differentiation.

Authors:  K Mizutani; T Matsubayashi; S Iwase; T S Doi; K Kasai; M Yazaki; Y Wada; T Takahashi; Y Obata
Journal:  Cell Struct Funct       Date:  2000-02       Impact factor: 2.212

4.  The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro.

Authors:  L Walker; M Lynch; S Silverman; J Fraser; J Boulter; G Weinmaster; J C Gasson
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

5.  Modulated expression of notch1 during thymocyte development.

Authors:  R P Hasserjian; J C Aster; F Davi; D S Weinberg; J Sklar
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  mNotch1 signaling reduces proliferation of myeloid progenitor cells by altering cell-cycle kinetics.

Authors:  T Schroeder; U Just
Journal:  Exp Hematol       Date:  2000-11       Impact factor: 3.084

7.  Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells.

Authors:  C Caux; I Moreau; S Saeland; J Banchereau
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

8.  Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage.

Authors:  O Sakamoto; M Hashiyama; A Minty; M Ando; T Suda
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells.

Authors:  F Radtke; I Ferrero; A Wilson; R Lees; M Aguet; H R MacDonald
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

View more
  13 in total

Review 1.  Notch signaling in differentiation and function of dendritic cells.

Authors:  Pingyan Cheng; Dmitry Gabrilovich
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.

Authors:  Adriana Heguy; Timothy P O'Connor; Karsta Luettich; Stefan Worgall; Adam Cieciuch; Ben-Gary Harvey; Neil R Hackett; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-03-07       Impact factor: 4.599

3.  Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia.

Authors:  Dan Li; Tongjuan Li; Zhen Shang; Lei Zhao; Qian Xu; Jiaqi Tan; Yun Qin; Yuanyuan Zhang; Yang Cao; Na Wang; Liang Huang; Xiaojian Zhu; Kuangguo Zhou; Liting Chen; Chunrui Li; Ting Xie; Yi Yang; Jue Wang; Jianfeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2020-03-13

4.  Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation.

Authors:  Karthikeyan Veeraraghavalu; Vanitha K Subbaiah; Sweta Srivastava; Oishee Chakrabarti; Ruchi Syal; Sudhir Krishna
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.

Authors:  Maria Duarte; Vihren Kolev; Doreen Kacer; Carla Mouta-Bellum; Raffaella Soldi; Irene Graziani; Aleksandr Kirov; Robert Friesel; Lucy Liaw; Deena Small; Joseph Verdi; Thomas Maciag; Igor Prudovsky
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

6.  Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation.

Authors:  Karthikeyan Veeraraghavalu; Mark Pett; Rekha V Kumar; Pradip Nair; Annapoorni Rangarajan; Margaret A Stanley; Sudhir Krishna
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Immunolocalization of notch signaling protein molecules in a maxillary chondrosarcoma and its recurrent tumor.

Authors:  C H Siar; K O Ha; L O Aung; K Nakano; H Tsujigiwa; H Nagatsuka; K H Ng; Toshiyuki Kawakami
Journal:  Eur J Med Res       Date:  2010-10-25       Impact factor: 2.175

8.  PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling.

Authors:  Kushagra Bansal; Nisha Kapoor; Yeddula Narayana; Germain Puzo; Martine Gilleron; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

9.  Notch activation inhibits AML growth and survival: a potential therapeutic approach.

Authors:  Sankaranarayanan Kannan; Robert M Sutphin; Mandy G Hall; Leonard S Golfman; Wendy Fang; Riitta M Nolo; Lauren J Akers; Richard A Hammitt; John S McMurray; Steven M Kornblau; Ari M Melnick; Maria E Figueroa; Patrick A Zweidler-McKay
Journal:  J Exp Med       Date:  2013-01-28       Impact factor: 14.307

10.  Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia.

Authors:  Dan Li; Tongjuan Li; Zhen Shang; Lei Zhao; Qian Xu; Jiaqi Tan; Yun Qin; Yuanyuan Zhang; Yang Cao; Na Wang; Liang Huang; Xiaojian Zhu; Kuangguo Zhou; Liting Chen; Chunrui Li; Ting Xie; Yi Yang; Jue Wang; Jianfeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.